The Sabin Vaccine Institute has begun a Phase II trial in the US to evaluate its Marburg vaccine, with the first doses being ...

The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, ...

The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, administering doses to the ...

On January 20, Tanzania declared an outbreak of Marburg virus disease, which ended on March 13. For the U.S. clinical trial that began this week, Sabin will recruit 200 volunteers aged 18 to 70 across ...

It’s been five years since the COVID-19 pandemic changed everything—from the way we work to the way we think about global health. But what if another pandemic strikes tomorrow? Will the world be any ...

World Health Organization members are finalizing plans for nations to share life-saving technology with developing countries ...

He reiterated the need for the inclusion of yellow fever treatment under the NHIS, as it remains one of the most viral endemic diseases in Ghana and Africa. Kwabena called on the government to take ...

Marburg virus belongs to the genus Marburgvirus in the family Filoviridae and causes a severe hemorrhagic fever, known as Marburg hemorrhagic fever (MHF), in both humans and nonhuman primates.

Yet, no country is required to allow citizens of another country to enter. Governments can issue a ban on travel for any ...

Rwanda’s tourism industry raked in $647 million (approx. Rwf923billion) revenue in 2024, representing a slight increase of 4.3 percent compared to 2023, according to an annual Rwanda Development Board ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

Complex Pandemic Accord negotiations have been underway since 2021, with 13 formal meetings and numerous informal sessions.